Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.

Viktor Molander Hannah Bower Thomas Frisell Bénédicte DelcoigneDaniela Di GiuseppeJohan Asklingnull null

Published in: Annals of the rheumatic diseases (2022)

Patients with RA treated with JAKi in clinical practice are at increased risk of VTE compared with those treated with bDMARDs, an increase numerically confined to PE.

Keyphrases

venous thromboembolism
clinical practice
direct oral anticoagulants